BillionToOne is a next-generation molecular diagnostics company focused on creating powerful, highly accurate tests that are accessible to all
BillionToOne is a next-generation molecular diagnostics company focused on creating powerful, highly accurate tests that are accessible to all. Built on its proprietary molecular counting platform, the company develops diagnostics that can measure DNA at the single-molecule level, enabling a new standard of precision across both prenatal and oncology care.